Gossypin Up-Regulates LDL Receptor through Activation of ERK Pathway: A Signaling Mechanism for the Hypocholesterolemic Effect
Gossypin Up-Regulates LDL Receptor through Activation of ERK Pathway: A Signaling Mechanism for the Hypocholesterolemic Effect
复制标题
DOI:
10.1021/jf802607x
复制
发表时间:
2008-12-10
影响因子:
6.1
通讯作者:
Sun, Chang-Hao
中科院分区:
文献类型:
--
作者:
Lu, Na;Li, Ying;Sun, Chang-Hao
Hypercholesterolemia is one of the major risk factors for the development of cardiovascular disease. This study aims to elucidate the effect of gossypin on cholesterol metabolism in HepG2 cells. Results indicated that gossypin significantly reduced the total cholesterol concentration in a dose-dependent manner. There was a time- and dose-dependent increase in the expression of low-density lipoprotein receptor (LDLR) protein. However, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol synthesis, was not affected by gossypin. Moreover, gossypin had no effect on nuclear sterol regulatory element binding proteins (SREBP)-2 abundance. The activity of gossypin on LDLR expression was inhibited by the extracellular signal-regulated kinase (ERK) inhibitor PD98059, Western blotting analysis revealed that gossypin treatment close- and time-dependently increased ERK activation and preceded the up-regulation of LDLR expression. Collectively, these new findings identify gossypin as a new hypocholesterolemic agent that up-regulates LDLR expression independent of SREBP-2 but is dependent on ERK activation.